Acta Ophthalmologica · 2015 · 29 citations · 15 references
MedicineOphthalmologyVision ScienceOcular DiseaseOcular PathologyVisual DisordersAge-related Macular DegenerationDiabetic RetinopathyMacular DegenerationMacular DiseaseMacular DisordersRetinal Vascular DiseaseAnti-vegf Ocular TherapyMacular Dysfunction AssessmentMacular Edema EvaluationMacular NeovascularizationNeovascular Macular DegenerationNeovascularizationOcular Manifestations Of DiabetesRetinal Vein Occlusion Therapy
PURPOSE: To quantify subjective visual metamorphopsia in newly diagnosed patients suffering from diabetic macular oedema (DME) and other macular abnormalities and to evaluate anti-VEGF treatment effect. METHODS: Patients with DME, subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) or retinal venous occlusion (RVO) were recruited. Metamorphopsia score (Mscore) was calculated using M-Charts at baseline and at the end of a series of anti-VEGF injections. RESULTS: Fifteen eyes of 10 patients with DME, 14 eyes of 13 patients with AMD-CNV and five patients with RVO were included in this study. At baseline, positive Mscore was observed in 46.6% of eyes with DME, 50% of eyes with AMD-CNV and four of five eyes with RVO. Treatment led to a complete metamorphopsia reduction (Mscore = 0) in 71.4% of DME patients, 35.7% of AMD and 0% of RVO patients. CONCLUSION: We suggest that the M-charts may serve as an additional test for diagnosis and follow-up, complementary to morphological evaluation by imaging, in diabetic patients facing their first anti-VEGF treatment.
15
Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld et al. · American Journal of Ophthalmology · 2007 · 972 citations
Earliest Symptoms of Diseases of the Macula
M. Amsler · British Journal of Ophthalmology · 1953 · 185 citations · Full text
The burden of age-related macular degeneration: a value-based analysis.
Melissa M. Brown, Gary C. Brown, Sanjay Sharma et al. · PubMed · 2006 · 100 citations